HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

490.383

-13.015-2.59%

Number of Gainers:6

Number of Losers:23

Number of Flat:4

PE:- -

High:505.901

Open:503.516

Low:489.571

Close:503.398

Volume:82.72M

Turnover:2.69B

Market Cap:313.43B

Float Cap:277.25B

Loading ...

US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market

CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses

Simply Wall St.

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

SinoMab BioScience Schedules Board Meeting to Review Interim Results

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

Penalty Finalized for Nanxin Pharmaceutical Over Disclosure Violations, Affected Investors Invited to Register Claims

China's AI-Driven Drug Discovery Sector Poised for Clinical Breakthroughs and Commercial Growth, Analyst Says

Shinva Medical Secures Class III Medical Device Certification for Single-Use Plasma Surgical Electrode

This Sector Is Experiencing a Major Surge

What We're Really Talking About When We Discuss Innovative Drugs Today

HK Stock Alert | Zai Lab Surges Nearly 7% in Morning Trade as argenx's FcRn-Targeted Drug Succeeds in Phase 3 Trial; Zai Holds Greater China Rights

CARSGEN-B Surges Nearly 5% Post-Earnings as Mid-Year Revenue Climbs 21.5% to RMB 61.9 Million

Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?

Antengene Says Phase II Gastric Cancer Study Shows 46.7% ORR for ATG-022 at 1.8 Mg/kg Dose

Press Release: CARsgen Therapeutics Announces 2026 Interim Results

EVEREST MED Posts Strong Interim Results with Revenue Soaring 157% as Nefecon Commercial Launch and Real-World Data Gain Momentum

Everest Medicines H1 Revenue RMB 701.7 Million

THOMSON REUTERS

Everest Medicines FY26 H1 Net Loss Narrows to RMB 5.9 Million; Revenue More than Doubles to RMB 1.15 Billion

CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK1574/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":490.383,"timestamp":1788250091886,"preClose":503.39795,"halted":0,"volume":82724645,"delay":0,"changeRate":-0.025854,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-13.014954,"latestTime":"09-01 16:00:00","open":503.51608,"high":505.9005,"low":489.5706,"amount":2688849767,"amplitude":0.032439,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"pbRate":3.790203,"peRate":127.340212,"turnoverRate":0.003099,"increases":6,"decrements":23,"flats":3,"marketCap":313429262448,"floatMarketCap":277247178824},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":505.9005,"amplitude":0.032439,"preClose":503.39795,"low":489.5706,"pbRate":"3.790203","latestPrice":490.383,"volume":82724645,"delay":0,"open":503.51608,"prevYearClose":556.26263,"prevWeekClose":523.873,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.773,"twentyDayClose":475.248,"sixtyDayClose":459.637,"secType":"PLATE","market":"HK","turnoverRate":0.003099,"peRate":127.340212,"marketCap":313429262448,"floatMarketCap":277247178824,"timestamp":1788250091886,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":23,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171659413","title":"US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1171659413","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171659413?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:59","pubTimestamp":1787144382,"startTime":"0","endTime":"0","summary":"Global technology equities faced a brutal selloff that originated on Wall Street, with the Philadelphia Semiconductor Index (SOX) plunging 4.98% overnight as all 30 constituent stocks closed lower,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU0417516902.SGD","LU0417516738.SGD","VCIT","LU2778985437.USD","LU0918141887.USD","00300","LU0348827113.USD","PY","MTNmain","BOND","ISHG","LU0708995583.HKD","EDV","LU0039217434.USD","ROPE","ZTmain","LU2226246903.HKD","LU0540923850.HKD","LU0594300179.USD","BK1588","LU0463099449.HKD","LU0634319403.HKD","LU2039709279.SGD","TLTX","LU1981816686.USD","LU0675040207.SGD","TALV","VLUE","LU0359201885.HKD","BK4581","MIUmain","LU0320764599.SGD","LU0823397103.USD","XIACY","ABEQ","LU0823038988.USD","BK1193","LU0823426480.USD","LU0594300419.USD","LU1323998911.USD","BK1110","VGSH","HK0000306701.USD","VCSH","HK0000306685.HKD","LU1328277881.USD","LU0052750758.USD","LU1481107354.HKD","LU0326950275.SGD","BND","LU0797268264.HKD","UBmain","LU2097828631.EUR","XBIL","VALQ","LU0359202008.SGD","DRGN","01810","LU0210526637.USD","TNmain","TLTW","LU1303224171.USD","LU2257852520.SGD","SWP","USHY","HXXD.SI","CIVG","LU1188198961.HKD","LU2097828714.EUR","SG9999002463.SGD","VGIT","01907","BK1141","LU0164872284.USD","LU0441854154.USD","IE0032431581.USD","LU2087589342.USD","TBIL","LU1105468828.SGD","SG9999003461.SGD","GBIL","HK0000286598.CNH","IEI","LU0054450605.USD","LU0348825331.USD","LU0214875030.USD","MYCN","LU0531970944.HKD","LU0143863784.USD","LU0345776255.USD","LU1868838027.USD","LU0449509016.USD","LU0572944931.SGD","UTRE","LU0871576103.HKD","LU0456846285.SGD","LU2488822045.USD","LU1961090484.USD","LU0169518387.USD","LU0117841782.USD","LU0211977185.USD","LU1868837565.USD","ZROZ","LU2097828557.USD","LU2476274308.USD","LU0327786744.USD","LU0650527681.SGD","LU0605514214.HKD","LU1770034418.SGD","BK1618","HK0000165453.HKD","LU0823397285.USD","LU1023057109.AUD","LU0918141705.HKD","EQRR","LU0611395673.USD","LU1808992512.USD","LU2097828805.USD","LU2399975544.HKD","BK4535","VXUS","DBND","HYG","BBSB","PRF","BK4561","SG9999001093.SGD","IE00B0169L03.USD","LU0499858602.USD","LQD","LU0499858438.USD","WAMA","LU0823040885.USD","BK4550","LU0051755006.USD","LU1880383440.USD","LU0348814723.USD","VUSV","HK0000320264.USD","LU1813983027.USD","BITC","BSV","LU0143863198.USD","BK1574","BK1521","DFLV","LU1880383366.USD","LU1956131251.USD","LU0823413660.USD","TLTI","AGG","GOVT","LU0561508036.HKD","TIP","UTWY","NGHT","LU1770036033.HKD","USVN","VTV","LU2294711473.HKD","LU0456827905.SGD","LU0531971595.HKD","LU0164880469.USD","LU0149721374.USD","LU0823413587.USD","VGLT","BK1583","BK1607","BK1502","LU0254981946.USD","KCAI","BIL","LU1251922891.USD","BK1610","MUNX","LU0359201612.USD","LU1960683339.HKD","BK1575","HK0000320223.HKD","LU0823426308.USD","TMF","LU0449515922.USD","IGOV","BKDV","LU0588546209.SGD","SHV","HMOP","IE0034224299.USD","MUB","LU0164865239.USD","LU0700851271.USD","IE00B3M56506.USD","FLGV","BK1589","BNDW","LU0345775950.USD","LU0823041008.USD","BK4588","LU0348735423.USD","LU2097828474.EUR","TBJL","TBT","ZFmain","TLT","LU0348816934.USD","TSYW","SGOV","ZNmain","LU0307460666.USD","BK4504","LU0823039010.USD","LU0593848301.USD","LU1807302812.USD","01548","MWNmain","JPST","UBT","UFIV","09688","LU0084288322.USD","BBIB","LU0231483743.USD","BK1615","BWX","BWZ","BK1576","LU0314109678.HKD","BK4585","SPVM","IEF","LU0235996351.USD","LU0244354667.USD","LU1282648689.USD","BK1506","GOLY","UTHY","VMAX","BK1214","MINT","ZBmain","BOXX","81810","LU1720050803.USD","LU1794554557.SGD","BK1523","TFJL","BBLB","SCHO","SHY","CGVV","LU2152927971.USD","LIAJ","LU1719994722.HKD","BK1161","LU1993786604.SGD","TLH","TYO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431424","title":"CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431424?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:27","pubTimestamp":1787142431,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings closed at HK$14.90 today after a choppy few months in which the stock has slipped about 15% over 90 days. Yet behind the weak chart, the latest half year numbers point to one issue that matters most for you as a shareholder. The balance sheet and valuation strain is now the key tension between short term sentiment and long term promise.\nRevenue for the first half of 2026 came in at ¥61.9 million, while the company still reported a net loss of ¥66.7 million. With...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1587","LENZ","BK4539","02171","BK4007","BK1574","BK4139","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660702428","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660702428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660702428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:25","pubTimestamp":1787142331,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return, lifts share capital by 250,000 sharesZylox-Tonbridge filed a next-day disclosure return covering a transfer of 250,000 H Shares from treasury on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL5sPjqv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK0012","BK0060","LU2495084118.USD","BK1191","LU1820825898.SGD","BK1161","LU1997245177.USD","LU1064131003.USD","LU2097828714.EUR","BK0239","LU2580892789.USD","LU2097828631.EUR","LU2097828805.USD","MEDX","LU2148510915.USD","LU1023057109.AUD","LU1146622755.USD","600276","BK0188","LU1969619763.USD","LU1655091616.SGD","IBBQ","LU1064130708.USD","159992","BK0183","LU1997245094.SGD","LU1781817850.SGD","LU1255011170.USD","LU2328871848.SGD","LU0405327148.USD","LU1328615791.USD","LU0359201885.HKD","LU1580142542.USD","LU2097828474.EUR","LU2580892862.HKD","LNGR","LU2543165471.USD","LU0359201612.USD","01276","LU1997244956.HKD","LU2097828557.USD","BK1574","LU0359202008.SGD","LU0405327494.USD","BK0028","BK0196","LU2488822045.USD","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447344","title":"SinoMab BioScience Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447344?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137487,"startTime":"0","endTime":"0","summary":"SinoMab BioScience schedules board meeting to review interim resultsSinoMab BioScience set a board meeting for Aug. 31, 2026 to review the group’s interim results for the six months ended June 30, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4cbBb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197235257","title":"BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths","url":"https://stock-news.laohu8.com/highlight/detail?id=1197235257","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197235257?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:36","pubTimestamp":1787128594,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced that its majority-owned subsidiary, Guangzhou Baiyunshan Tiansin Pharmaceutical Co., Ltd., recently received the Drug Supplement Application Approval Notice from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1574","BK0012","01477","BK0196","00874","BK0096","BK1606","BK0183","BK0070","BK0028","BK1521","600332","BK1191","BK0097","BK1197","BK1515","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144883245","title":"Penalty Finalized for Nanxin Pharmaceutical Over Disclosure Violations, Affected Investors Invited to Register Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1144883245","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144883245?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:20","pubTimestamp":1787127636,"startTime":"0","endTime":"0","summary":"Nanxin Pharmaceutical has officially received its penalty after an investigation into annual report disclosure violations, and eligible investors are now being encouraged to register for potential...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117891527","title":"China's AI-Driven Drug Discovery Sector Poised for Clinical Breakthroughs and Commercial Growth, Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1117891527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117891527?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:18","pubTimestamp":1787127519,"startTime":"0","endTime":"0","summary":"China Merchants Securities has released a research report indicating that AI-powered drug discovery has entered the clinical validation phase, with a commercial surge on the horizon. As the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06099","BK0012","600999","BK0183","QTOC","AIPO","BK0028","CHAT","BK0188","BK1191","ARTY","01477","VTHR","BK1564","BK1574","AGIX","BK0010","BK0276","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128583126","title":"Shinva Medical Secures Class III Medical Device Certification for Single-Use Plasma Surgical Electrode","url":"https://stock-news.laohu8.com/highlight/detail?id=1128583126","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128583126?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:48","pubTimestamp":1787125716,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co., Ltd. (600587.SH) announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., has recently received the Medical Device Registration Certificate issued by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK0188","09996","159883","HART","RSPH","GDOC","BK1583","BK0028","LGHT","LNGR","PTH","IEIH","MDEV","BK0251","AGNG","BK1574","MEDX","600587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166888801","title":"This Sector Is Experiencing a Major Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1166888801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166888801?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:00","pubTimestamp":1787119253,"startTime":"0","endTime":"0","summary":"Since the technology sector cooled off in July, the innovative drug industry chain has taken the lead in market performance. The sector has risen considerably, with leading player Wuxi AppTec...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1574","06978","BK1161","IBBQ","09939","LNGR","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178011845","title":"What We're Really Talking About When We Discuss Innovative Drugs Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1178011845","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178011845?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:20","pubTimestamp":1787109655,"startTime":"0","endTime":"0","summary":"When we talk about innovative drugs, we can't just look at innovative drugs alone. BD out-licensing, the scientific research services and CXO opportunities brought by AI-driven drug development, and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","MEDX","IBBQ","BK1161","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195982409","title":"HK Stock Alert | Zai Lab Surges Nearly 7% in Morning Trade as argenx's FcRn-Targeted Drug Succeeds in Phase 3 Trial; Zai Holds Greater China Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=1195982409","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195982409?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:16","pubTimestamp":1787109373,"startTime":"0","endTime":"0","summary":"Zai Lab Ltd (HK: 09688) jumped nearly 7% in early trading on Friday, before settling up 4.61% at HK$20.18, with turnover reaching HK$131 million. The surge comes after immunology company argenx...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK4526","09688","BK4585","LU2488822045.USD","BK1588","BK4548","ZLAB","KCAI","BK4139","VXUS","BK1574","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155552295","title":"CARSGEN-B Surges Nearly 5% Post-Earnings as Mid-Year Revenue Climbs 21.5% to RMB 61.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1155552295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155552295?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:20","pubTimestamp":1787106032,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its shares rally nearly 5% in Thursday morning trade following the release of its interim results. The stock was up 4.63% at HK$15.38 at the time of writing, with turnover...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1574","02171","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109518315","title":"Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?","url":"https://stock-news.laohu8.com/highlight/detail?id=1109518315","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109518315?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:11","pubTimestamp":1787105475,"startTime":"0","endTime":"0","summary":"The biopharmaceutical sector has once again captured the spotlight in the financial markets. According to data from Gongmu Paipai.com, between August 3 and August 9, public offering institutions...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","MEDX","LNGR","IBBQ","159992","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413291","title":"Antengene Says Phase II Gastric Cancer Study Shows 46.7% ORR for ATG-022 at 1.8 Mg/kg Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413291?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:00","pubTimestamp":1787101229,"startTime":"0","endTime":"0","summary":"Antengene says Phase II gastric cancer study shows 46.7% ORR for ATG-022 at 1.8 mg/kg doseAntengene presented updated Phase II CLINCH data for ATG-022, a CLDN18.2 ADC, at the Evercore 2nd China Biotec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL5gksF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1574","BK1191","BK1583","EVR","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660241822","title":"Press Release: CARsgen Therapeutics Announces 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660241822","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660241822?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:15","pubTimestamp":1787098500,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited , a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Results.Business Highlights-- Cash and cash equivalents were around RMB1,400 million as of June 30,2026. Cash and cash equivalents at the end of 2026 are expected to be not. less than RMB1,200 million. In light of operational factors, we expect to. -- During H1, 2026, CARsgen has received a total of 110 confirmed orders of. -- Satri-cel receives NMPA approval in June 2026 as world's first and only. CAR-T for solid tumors. Data of satri-cel as sequential therapy after 1L. treatment in patients with G/GEJA have been presented at the 2026 ASCO. -- Multiple allogeneic CAR T-cell products are under development based on. the proprietary THANK--u Plus platform. Among them, research results. for CT0596 in the treatment of R/R MM and PCL, as well as for CT1190B in. the treatment of R/R B--NHL, have been presented at the E","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIBR","02171","LU2462157665.USD","SG9999001424.SGD","IE00B42XCP33.USD","CSCO","BK4230","BK0187","BK1574","LU1221951129.SGD","IE00B1BXHZ80.USD","000963","IE00BVYPNV92.GBP","LU0950375773.USD","IE00B3PB1722.GBP","CSCS","PC","BK4534","LENZ","LU1046421795.USD","BK0209","BK4515","TM","LU2328871848.SGD","LU1599440770.SGD","CAR","03160","BK4612","BK1587","IYZ","LU0070302665.USD","LU2506952097.USD","LU2237443622.USD","LU0823417653.USD","LU1929549753.HKD","LU2417539215.USD","CSCL","LU1674673428.USD","LU2237443465.HKD","BK4022","AIQ","LU0942090050.USD","BK4560","LU1430594728.SGD","LU0868494617.USD","R","SG9999001440.SGD","LU0203345920.USD","BK4533","LU1032955483.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123558217","title":"EVEREST MED Posts Strong Interim Results with Revenue Soaring 157% as Nefecon Commercial Launch and Real-World Data Gain Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1123558217","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123558217?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:14","pubTimestamp":1787094857,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) has announced its interim results for the six months ended June 30, 2026, with revenue reaching RMB 1.148 billion, a substantial 157.29% increase year-over-year.Gross profit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01952","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660901934","title":"Everest Medicines H1 Revenue RMB 701.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660901934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660901934?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:54","pubTimestamp":1787093697,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLX21FCWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","01952","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490157","title":"Everest Medicines FY26 H1 Net Loss Narrows to RMB 5.9 Million; Revenue More than Doubles to RMB 1.15 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490157","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490157?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:53","pubTimestamp":1787093594,"startTime":"0","endTime":"0","summary":"Everest Medicines FY26 H1 net loss narrows to RMB 5.9 million; revenue more than doubles to RMB 1.15 billionEverest Medicines posted IFRS revenue of RMB 1.15 billion, more than doubled from a year ear","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLb6NYw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494978","title":"CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494978","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494978?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:24","pubTimestamp":1787077458,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh attention after its allogeneic CAR T-cell candidate CT0596 received IND clearance from China’s National Medical Products Administration for relapsed or refractory multiple myeloma.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe CT0596 IND clearance arrives as CARsgen Therapeutics Holdings trades at HK$14.7, with a 1 day share price return of 2.15% and a 90 day share price return down 16.62%. The 1 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","BK4539","02171","BK4007","LENZ","IND","BK1585","BK1587","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":19,"totalSize":380,"code":"91000000","status":"200"}]}}